Millennium Management’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,259
Closed -$68K 5401
2022
Q2
$68K Buy
+20,259
New +$68K ﹤0.01% 4777